相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)
Henri Stalder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Behavioral effects of clozapine: Involvement of trace amine pathways in C. elegans and M. musculus
Rakesh Karmacharya et al.
BRAIN RESEARCH (2011)
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity
Gregory M. Miller
JOURNAL OF NEUROCHEMISTRY (2011)
RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Trace amines and their relevance to psychiatry and neurology: a brief overview / Eser aminler ve psikiyatri ve nöroloji ile ilişkisi: Kısa bir gözden geçirme
Deepak Narang et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza et al.
MOLECULAR PHARMACOLOGY (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential
Daniela Alberati et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Preclinical models of antipsychotic drug-induced metabolic side effects
Heidi N. Boyda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Anatomical and histological profiling of orphan G-protein-coupled receptor expression in gastrointestinal tract of C57BL/6J mice
Junko Ito et al.
CELL AND TISSUE RESEARCH (2009)
Trace Amine-Associated Receptors as Emerging Therapeutic Targets
Tatyana D. Sotnikova et al.
MOLECULAR PHARMACOLOGY (2009)
Validation of Cerebral Blood Perfusion Imaging as a Modality for Quantitative Pharmacological MRI in Rats
Andreas Bruns et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
Amyaouch Bradaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
Theresa M. Ballard et al.
PSYCHOPHARMACOLOGY (2009)
Modulation of stress by imidazoline binding sites: Implications for psychiatric disorders
Karen L. Smith et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2009)
Anatomical Profiling of G Protein-Coupled Receptor Expression
Jean B. Regard et al.
CELL (2008)
Enhancing Aromatic L-amino Acid Decarboxylase Activity: Implications for L-DOPA Treatment in Parkinson's Disease
Maria Hadjiconstantinou et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats
R. E. Nordquist et al.
NEUROPHARMACOLOGY (2008)
Selective 5HT(2A) and 5HT(6) receptor antagonists promote sleep in rats
Stephen R. Morairty et al.
SLEEP (2008)
Better pharmacotherapy for schizophrenia: What does the future hold?
Michael A. Webber et al.
Current Psychiatry Reports (2008)
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
K. Rutten et al.
PSYCHOPHARMACOLOGY (2008)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The evolution of drug development in schizophrenia: Past issues and future opportunities
William T. Carpenter et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: Comparison among antipsychotics
Joshua S. Rodefer et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Expression of neuronal trace arnine-associated receptor (Taar) mRNAs in leukocytes
Daniel A. Nelson et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Trace amine-associated receptor 1 - Family archetype or iconoclast?
David K. Grandy
PHARMACOLOGY & THERAPEUTICS (2007)
The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. D. Wolinsky et al.
GENES BRAIN AND BEHAVIOR (2007)
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
Charles H. Large
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
M. D. Berry
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: Reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence
Subimal Datta et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain
Scott A. Burchett et al.
PROGRESS IN NEUROBIOLOGY (2006)
The NIMH-MATRICS consensus statement on negative symptoms
B Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2006)
Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia
C Risterucci et al.
PSYCHOPHARMACOLOGY (2005)
A renaissance in trace amines inspired by a novel GPCR family
L Lindemann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors
L Lindemann et al.
GENOMICS (2005)
PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats
JS Rodefer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule
JM O'Donnell et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
A Abi-Dargham et al.
EUROPEAN PSYCHIATRY (2005)
Drug induced weight gain, an impediment to successful pharmacotherapy:: Focus on antipsychotics
T Baptista et al.
CURRENT DRUG TARGETS (2004)
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice
JF Cryan et al.
MOLECULAR PSYCHIATRY (2004)
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green et al.
BIOLOGICAL PSYCHIATRY (2004)
Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry
B Künnecke et al.
OBESITY RESEARCH (2004)
Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia
A Abi-Dargham et al.
NEUROSCIENTIST (2003)
HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes
G D'Andrea et al.
NEUROSCIENCE LETTERS (2003)
The impact of weight gain on quality of life among persons with schizophrenia
DB Allison et al.
PSYCHIATRIC SERVICES (2003)
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Genetic animal models: focus on schizophrenia
RR Gainetdinov et al.
TRENDS IN NEUROSCIENCES (2001)
Trace amines: Identification of a family of mammalian G protein-coupled receptors
B Borowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
A Carlsson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex
GL Gessa et al.
NEUROPSYCHOPHARMACOLOGY (2000)